Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS
Tài liệu tham khảo
Hudry, 2019, Therapeutic AAV gene transfer to the nervous system: a clinical reality, Neuron, 102, 263, 10.1016/j.neuron.2019.03.020
Ogden, 2019, Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design, Science, 366, 1139, 10.1126/science.aaw2900
Aschauer, 2013, Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain, PLoS ONE, 8, e76310, 10.1371/journal.pone.0076310
Bedbrook, 2018, Viral strategies for targeting the central and peripheral nervous systems, Annu. Rev. Neurosci., 41, 323, 10.1146/annurev-neuro-080317-062048
Chan, 2017, Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems, Nat. Neurosci., 20, 1172, 10.1038/nn.4593
Dayton, 2018, More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B, Gene Ther., 25, 392, 10.1038/s41434-018-0028-5
Delzor, 2012, Restricted transgene expression in the brain with cell-type specific neuronal promoters, Hum. Gene Ther. Methods, 23, 242, 10.1089/hgtb.2012.073
Peel, 1997, Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters, Gene Ther., 4, 16, 10.1038/sj.gt.3300358
Sohal, 2009, Parvalbumin neurons and gamma rhythms enhance cortical circuit performance, Nature, 459, 698, 10.1038/nature07991
Qin, 2010, Systematic comparison of constitutive promoters and the doxycycline-inducible promoter, PLoS ONE, 5, e10611, 10.1371/journal.pone.0010611
Gray, 2011, Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors, Hum. Gene Ther., 22, 1143, 10.1089/hum.2010.245
Nathanson, 2009, Short promoters in viral vectors drive selective expression in mammalian inhibitory neurons, but do not restrict activity to specific inhibitory cell-types, Front. Neural Circuits, 3, 19, 10.3389/neuro.04.019.2009
Brooks, 2004, Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle, J. Gene Med., 6, 395, 10.1002/jgm.516
Bäck, 2019, Neuronal activation stimulates cytomegalovirus promoter-driven transgene expression, Mol. Ther. Methods Clin. Dev., 14, 180, 10.1016/j.omtm.2019.06.006
Husain, 2009, Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters, Gene Ther., 16, 927, 10.1038/gt.2009.52
Koyuncu, 2013, Virus infections in the nervous system, Cell Host Microbe, 13, 379, 10.1016/j.chom.2013.03.010
Berthomme, 2000, Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency, J. Virol., 74, 3613, 10.1128/JVI.74.8.3613-3622.2000
Lokensgard, 1997, The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency, J. Virol., 71, 6714, 10.1128/jvi.71.9.6714-6719.1997
Cheung, 1989, Detection of pseudorabies virus transcripts in trigeminal ganglia of latently infected swine, J. Virol., 63, 2908, 10.1128/jvi.63.7.2908-2913.1989
Priola, 1991, The 5′ and 3′ limits of transcription in the pseudorabies virus latency associated transcription unit, Virology, 182, 852, 10.1016/0042-6822(91)90628-O
Cheung, 1991, Cloning of the latency gene and the early protein 0 gene of pseudorabies virus, J. Virol., 65, 5260, 10.1128/jvi.65.10.5260-5271.1991
Cheung, 1999, Analysis of the latency-associated transcript/UL1-3.5 gene cluster promoter complex of pseudorabies virus, Arch. Virol., 144, 381, 10.1007/s007050050511
Jin, 1999, Expression of the pseudorabies virus latency-associated transcript gene during productive infection of cultured cells, J. Virol., 73, 9781, 10.1128/JVI.73.12.9781-9788.1999
Jin, 2000, Identification of the pseudorabies virus promoter required for latency-associated transcript gene expression in the natural host, J. Virol., 74, 6333, 10.1128/JVI.74.14.6333-6338.2000
Taharaguchi, 2002, Analysis of regulatory functions for the region located upstream from the latency-associated transcript (LAT) promoter of pseudorabies virus in cultured cells, Vet. Microbiol., 85, 197, 10.1016/S0378-1135(01)00513-2
Deshmane, 1989, During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure, J. Virol., 63, 943, 10.1128/jvi.63.2.943-947.1989
Taharaguchi, 2003, The latency-associated transcript promoter of pseudorabies virus directs neuron-specific expression in trigeminal ganglia of transgenic mice, J. Gen. Virol., 84, 2015, 10.1099/vir.0.19080-0
Nguyen, 2018, RSAT 2018: regulatory sequence analysis tools 20th anniversary, Nucleic Acids Res., 46, W209, 10.1093/nar/gky317
Ziebarth, 2013, CTCFBSDB 2.0: a database for CTCF-binding sites and genome organization, Nucleic Acids Res., 41, D188, 10.1093/nar/gks1165
Wang, 2014, Transcription factor induction of human oligodendrocyte progenitor fate and differentiation, Proc. Natl. Acad. Sci. USA, 111, E2885, 10.1073/pnas.1408295111
Renier, 2014, iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging, Cell, 159, 896, 10.1016/j.cell.2014.10.010
Chan, 2018, Non-invasive measurement of mRNA decay reveals translation initiation as the major determinant of mRNA stability, eLife, 7, 7, 10.7554/eLife.32536
Deverman, 2018, Gene therapy for neurological disorders: progress and prospects, Nat. Rev. Drug Discov., 17, 767, 10.1038/nrd.2018.158
Ingusci, 2019, Gene therapy tools for brain diseases, Front. Pharmacol., 10, 724, 10.3389/fphar.2019.00724
Wang, 2019, Adeno-associated virus vector as a platform for gene therapy delivery, Nat. Rev. Drug Discov., 18, 358, 10.1038/s41573-019-0012-9
Chamberlain, 2016, Expressing transgenes that exceed the packaging capacity of adeno-associated virus capsids, Hum. Gene Ther. Methods, 27, 1, 10.1089/hgtb.2015.140
Colella, 2018, AAV gene transfer with tandem promoter design prevents anti-transgene immunity and provides persistent efficacy in neonate Pompe mice, Mol. Ther. Methods Clin. Dev., 12, 85, 10.1016/j.omtm.2018.11.002
Wang, 2002, Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson’s disease, Gene Ther., 9, 381, 10.1038/sj.gt.3301682
Cearley, 2007, A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease, J. Neurosci., 27, 9928, 10.1523/JNEUROSCI.2185-07.2007
Andersson, 2020, Determinants of enhancer and promoter activities of regulatory elements, Nat. Rev. Genet., 21, 71, 10.1038/s41576-019-0173-8
Emery, 2015, Transcriptional and epigenetic regulation of oligodendrocyte development and myelination in the central nervous system, Cold Spring Harb. Perspect. Biol., 7, a020461, 10.1101/cshperspect.a020461
Lang, 2017, CTCF interacts with the lytic HSV-1 genome to promote viral transcription, Sci. Rep., 7, 39861, 10.1038/srep39861
Lee, 2018, CCCTC-binding factor acts as a heterochromatin barrier on herpes simplex viral latent chromatin and contributes to poised latent infection, MBio, 9, e02372-17, 10.1128/mBio.02372-17
Zimmerman, 2018, Enhancement of transgene expression by nuclear transcription factor Y and CCCTC-binding factor, Biotechnol. Prog., 34, 1581, 10.1002/btpr.2712
Washington, 2018, CTCF binding sites in the herpes simplex virus 1 genome display site-specific CTCF occupation, protein recruitment, and insulator function, J. Virol., 92, e00156-18, 10.1128/JVI.00156-18
Haberman, 2002, Regulation of gene expression in adeno-associated virus vectors in the brain, Methods, 28, 219, 10.1016/S1046-2023(02)00226-8
Leib, 1991, The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency, Proc. Natl. Acad. Sci. USA, 88, 48, 10.1073/pnas.88.1.48
Baskerville, 1977, Experimental infection of monkeys with Herpesvirus suis (Aujeszky’s-disease virus), J. Med. Microbiol., 10, 139, 10.1099/00222615-10-1-139
Wong, 2019, Pseudorabies virus: a neglected zoonotic pathogen in humans?, Emerg. Microbes Infect., 8, 150, 10.1080/22221751.2018.1563459
Rincon, 2018, Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector, Gene Ther., 25, 83, 10.1038/s41434-018-0005-z
Patrício, 2017, Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-Driven transduction of mouse and human retina, Mol. Ther. Nucleic Acids, 6, 198, 10.1016/j.omtn.2016.12.006
Fagoe, 2014, A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons, Gene Ther., 21, 242, 10.1038/gt.2013.71
Ramezani, 2000, Lentiviral vectors for enhanced gene expression in human hematopoietic cells, Mol. Ther., 2, 458, 10.1006/mthe.2000.0190
Paterna, 2000, Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain, Gene Ther., 7, 1304, 10.1038/sj.gt.3301221
Xia, 2007, Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner, Stem Cells Dev., 16, 167, 10.1089/scd.2006.0057
Choi, 2014, Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons, Mol. Brain, 7, 17, 10.1186/1756-6606-7-17
Zolotukhin, 1999, Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Ther., 6, 973, 10.1038/sj.gt.3300938